Department of Thoracic Surgery, Cho Ray Hospital, 201B Nguyen Chi Thanh, Ward 12, District 5, Ho Chi Minh City, Viet Nam.
Department of Cardiovascular and Thoracic Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang, Ward 11, District 5, Ho Chi Minh City, Viet Nam.
World J Surg. 2020 Jul;44(7):2272-2279. doi: 10.1007/s00268-020-05432-2.
Large (≥3 cm) benign thyroid nodules usually cause clinical symptoms or cosmetic concerns and therefore require treatment. Microwave ablation (MWA) is a potential valid non-surgical treatment alternative, but there is a lack of evidence. Thus, this study is to evaluate the safety and efficacy of MWA in the treatment of large benign thyroid nodules.
A retrospective study was conducted on 42 large benign thyroid nodules in 40 patients treated with MWA. We used the trans-isthmic approach and moving-shot technique to perform the procedure under ultrasound (US) guidance. Patients were followed by clinical and US examinations at 1, 3, 6, and 12 months after the MWA. Study outcomes were complications, volume reduction ratio (VRR), symptom and cosmetic scores, and the requirement of multiple MWA sessions.
There were 31 females and 9 males, with a median age of 46 years. The medians of largest diameter and volume of the nodules were 40 mm and 22 ml. Four (10%) minor complications were observed. The mean VRR was 75.1, 85.2, and 96.4% after 3, 6, and 12 months. The mean symptom and cosmetic scores dropped from 8.0 and 3.8 (before treatment) to 2.8 and 2.3 (at 12 months), respectively. Thirteen nodules (31%) required two MWA sessions.
MWA is safe, effective, and can be a good option to treat large benign thyroid nodules. More studies with large dataset and long follow-up are required to improve its safety and efficacy.
大(≥3cm)良性甲状腺结节通常会引起临床症状或美容问题,因此需要治疗。微波消融(MWA)是一种潜在的有效非手术治疗选择,但缺乏证据。因此,本研究旨在评估 MWA 治疗大良性甲状腺结节的安全性和有效性。
对 40 例 42 个大良性甲状腺结节患者进行回顾性研究,采用经峡部入路和移动射击技术,在超声(US)引导下进行手术。患者在 MWA 后 1、3、6 和 12 个月进行临床和 US 检查。研究结果为并发症、体积减少率(VRR)、症状和美容评分以及多次 MWA 治疗的需求。
女性 31 例,男性 9 例,中位年龄 46 岁。结节最大直径和体积的中位数分别为 40mm 和 22ml。观察到 4 例(10%)轻微并发症。3、6 和 12 个月后 VRR 的平均值分别为 75.1%、85.2%和 96.4%。症状和美容评分从治疗前的 8.0 和 3.8 分别降至 12 个月时的 2.8 和 2.3。13 个结节(31%)需要进行两次 MWA 治疗。
MWA 是安全有效的,可作为治疗大良性甲状腺结节的一种良好选择。需要更多具有大数据集和长期随访的研究来提高其安全性和疗效。